Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Shares Outstanding (Diluted Average) (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Shares Outstanding (Diluted Average) for 15 consecutive years, with $44.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1.96% to $44.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.4 million through Dec 2025, up 1.96% year-over-year, with the annual reading at $44.4 million for FY2025, 1.96% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $44.4 million at Harvard Bioscience, roughly flat from $44.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $44.4 million in Q4 2025, with the low at $40.3 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $42.6 million, with a median of $42.7 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) fell 0.84% in 2023, then grew 2.94% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $40.3 million in 2021, then rose by 2.65% to $41.4 million in 2022, then rose by 2.43% to $42.4 million in 2023, then rose by 2.64% to $43.5 million in 2024, then rose by 1.96% to $44.4 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $44.4 million, $44.2 million, and $43.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.